TY - JOUR T1 - Clinical Outcomes and Survival Following Treatment of Metastatic Castrate-Refractory Prostate Cancer With Docetaxel Alone or With Strontium-89, Zoledronic Acid, or Both: The TRAPEZE Randomized Clinical Trial JO - JAMA Oncology UR - https://eprints.whiterose.ac.uk/101667/ PY - 2016/04/01 AU - James ND AU - Pirrie SJ AU - Pope AM AU - Barton D AU - Andronis L AU - Goranitis I AU - Collins S AU - Daunton A AU - McLaren D AU - O鈥橲ullivan J AU - Parker C et al ED - DO - DOI: 10.1001/jamaoncol.2015.5570 VL - 2 IS - 4 SP - 493 EP - 493 Y2 - 2025/05/30 ER -